May 24, 2023
Via: MedTech DiveIntegra initiated the voluntary recall after an internal investigation found endotoxin testing deviations. The deviations may have resulted in the release of medical devices with levels of endotoxins that exceed the levels permitted by the product specifications, the company said. […]
May 2, 2023
Via: MedTech DiveIn the multibillion-dollar market for diabetes technology, Medtronic’s U.S. diabetes sales have declined in the last four years as the company grappled with regulators and competitors rolled out new devices. With two strokes of a pen in late April, the […]
Industry Focus Areas, Medical, News
April 26, 2023
Via: MedTech DiveBoston Scientific reported first-quarter sales that exceeded the company’s forecast, saying it gained market share across its businesses as demand for procedures using its medical devices rebounded from a year ago. The company raised its full-year sales and profit forecasts, […]
April 11, 2023
Via: MedTech DiveMedical device trade groups raised concerns about the capacity to sterilize medical devices in response to proposed ethylene oxide regulations by the Environmental Protection Agency. The EPA seeks to reduce emissions of the gas, which it says can cause cancer […]
Industry Focus Areas, Medical, News
March 13, 2023
Via: The Wall Street JournalPfizer Inc. has agreed to pay $43 billion for biotech Seagen Inc. SGEN 16.29%increase; green up pointing triangle and its pioneering class of targeted cancer drugs. Under the terms, Pfizer would pay $229 a share in cash, the drugmaker said […]
February 14, 2023
Via: MedTech DiveJ&J’s case expanded from claiming Alcon infringed patents to accusing the company of stealing electronic copies of the source code for its own iFS Laser eye surgery device. According to J&J, Alcon “incorporated at least 26,000 lines of that code […]
February 2, 2023
Via: The Wall Street JournalEli Lilly & Co. said revenue for the recently ended quarter fell 9% as lower sales of its Covid-19 antibodies and the strong U.S. dollar weighed on growth. The pharmaceutical company said Thursday that quarterly revenue fell 9% to $7.30 […]
Design & Planning, Industry Focus Areas, Medical, Process
January 26, 2023
Via: MedTech DiveAs medical device companies strive to remain competitive and agile in today’s fast-paced world, they must center manufacturing in business optimization plans while embracing a design-to-value approach from the start. The COVID-19 pandemic accelerated the healthcare industry’s transformation, driving faster […]
January 10, 2023
Via: PR NewswirePrealize, an artificial intelligence (AI)-enabled predictive analytics company, today announced the release of its much anticipated, third annual State of Health Report. Prealize’s 2023 State of Health – In The Aftermath identifies the top at-risk conditions and utilization spikes that […]
January 9, 2023
Via: The Wall Street JournalAnglo-Swedish pharma giant AstraZeneca PLC has agreed to buy CinCor Pharma Inc., including global rights to its baxdrostat cardiorenal drug, for an upfront transaction value of around $1.3 billion. AstraZeneca said Monday that it will initiate a tender offer to […]
January 6, 2023
Via: The Wall Street JournalChinese drugmaker CanSino Biologics Inc. started trial production of a vaccine targeting new variants of Covid-19 that are behind the country’s current outbreak, which would be among the first developed in China using the mRNA technology that drove inoculation in […]
January 5, 2023
Via: MedTech DiveThe financial regulatory filing issued by Illumina to disclose the new $750 million credit facility is almost identical to its statement about the 2021 agreement. One of the options for setting the variable interest rate is now the “term secured […]
Design & Planning, Industry Focus Areas, Medical, Process
December 17, 2022
Via: Today's Medical DevelopmentsIn the era of value-based care, providers across the care spectrum are being measured (and compensated) on patient health outcomes. While nobody is arguing with the premise of that focus, many providers are struggling to adapt to the new measurement […]
December 6, 2022
Via: The Wall Street JournalEmergent BioSolutions Inc., maker of Narcan, a nasal-spray form of naloxone, said Tuesday that the U.S. Food and Drug Administration fast-tracked an application it submitted for an over-the-counter version of its widely used opioid-reversal nasal spray. The company said it […]
November 14, 2022
Via: PR NewswireEnglish actor, comedian and Monty Python alumnus Eric Idle credits early detection for his victory over pancreatic cancer, known as the world’s deadliest common cancer. “The good news is that we are starting to fight back,” said Idle after creating […]
November 8, 2022
Via: PR NewswireJiangsu Recbio Technology Co., Ltd. (the “Company”, together with its subsidiaries, the “Group”) is pleased to announce that positive results were achieved for its primary vaccination Phase II study in the Philippines and heterologous booster vaccination Phase II study in […]
November 3, 2022
Via: The Wall Street JournalModerna Inc.’s third-quarter revenue fell by nearly a third and the pharmaceutical company cut its outlook, saying as part of its earnings report that supply constraints for its Covid-19 vaccines might sap as much as $3 billion in sales this […]
October 31, 2022
Via: The Wall Street JournalRival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles. Merck & Co. has already introduced a new competitor […]
Industry Focus Areas, Medical, Regulations
October 20, 2022
Via: The Wall Street JournalDrugmakers are trying to blunt Medicare’s newfound power to negotiate medicine prices while coping with internal industry disputes and ebbing influence in Washington, D.C. Under the Inflation Reduction Act, Congress gave Medicare, the country’s biggest buyer of prescription drugs, the […]
October 13, 2022
Via: MedTech DiveGE Healthcare is taking steps to secure its supply of the substance used in x-rays and CT scans after shortages of iodinated contrast media led to doctors in the U.S. postponing nonemergency tests. The company said on Thursday that it […]